WCN26-7478 ASSOCIATION BETWEEN URINARY TUBULAR INJURY MARKERS AND BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE RECEIVING RIVAROXABAN

Read full text Summarise with VIRAT
Authors: Ranokhon Igamberdieva, Sherzod S. Abdullaev
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

In patients with chronic kidney disease (CKD), the presence of concomitant atrial fibrillation (AF) increases both the risk of thromboembolic complications and the risk of bleeding associated with the use of antithrombotic drugs. The risk of these complications is especially high in elderly and senile individuals. Currently, a number of markers of kidney damage have been identified, but the relationship between the level of their excretion in urine and the presence of bleeding in patients with CKD and AF receiving anticoagulants has not been sufficiently studied.

Fields of Study & Subjects

Atrial Fibrillation Management and Outcomes Acute Kidney Injury Research Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104525–104525
Publication date
25 March 2026
Language
EN